alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6614]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02329]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: NIGMS Initial Review Group Training and 
Workforce Development Study Section--B.
    Date: March 11, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892 (Video Meeting).
    Contact Person: Stephanie L. Constant, Ph.D., Scientific Review 
Officer, Office of Scientific Review, Division of Extramural 
Research Activities, National Institute of General Medical Sciences, 
National Institutes of Health, 45 Center Drive, Room 3AN12, 
Bethesda, MD 20892, 301-443-8784, <a href="/cdn-cgi/l/email-protection#70131f1e0304111e04031c301e181c12195e1e19185e171f06"><span class="__cf_email__" data-cfemail="ec8f83829f988d82989f80ac8284808e85c2828584c28b839a">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated January 31, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02329 Filed 2-3-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
|   | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  | May 6, 2011 |                                                         By: | /s/ Clifton R. Beckham                |   |
|--------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|--------|
|   |        |                                                                                                                                                                                                                                                                                                                                                | Clifton R. Beckham                    |   |
|   |        |                                                                                                                                                                                                                                                                                                                                                | President and Chief Executive Officer |   |
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Protocol
Systems, Inc. Condensed Consolidated Balance Sheet as of June 30, 1998 and
Condensed Consolidated Statement of Operations for the six months ended June 30,
1998.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           8,522
<SECURITIES>                                    12,008
<RECEIVABLES>                                   16,609<F1>
<ALLOWANCES>                                       391
<INVENTORY>                                     12,116
<CURRENT-ASSETS>                                47,376
<PP&E>                                          15,270
<DEPRECIATION>                                  10,720
<TOTAL-ASSETS>                                  58,050
<CURRENT-LIABILITIES>                            6,385
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            84
<OTHER-SE>                                      51,137
<TOTAL-LIABILITY-AND-EQUITY>                    58,050
<SALES>                                         31,880
<TOTAL-REVENUES>                                31,880
<CGS>                                           16,000
<TOTAL-COSTS>                                   16,000
<OTHER-EXPENSES>                                14,626
<LOSS-PROVISION>                                     0<F2>
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  1,254
<INCOME-TAX>                                       351
<INCOME-CONTINUING>                                903
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       903
<EPS-PRIMARY>                                     0.10
<EPS-DILUTED>                                     0.10
<FN>
<F1>Net of allowance
<F2>The amount of loss provision is not significant and has been included with
other expenses.
</FN>
        

</TABLE>
**EXHIBIT 32**

**SECTION 1350CERTIFICATIONS**

Theundersigned hereby certify that the annual report on Form 10-K ofInsight Communications Company, Inc. (the “Registrant”) for the year endedDecember 31, 2006, as filed with the Securities and Exchange Commission onthe date hereof (the “Report”), fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934, as amended, and that theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Registrant.

|   | /s/ MICHAEL  S. WILLNER      |
|--------|------------------------------|
|   | Michael S. Willner           |
|   | Vice Chairman and            |
|   | Chief Executive Officer      |
|   | March 27, 2007          |
|   | /s/ JOHN ABBOT               |
|   | John Abbot                   |
|   | Executive Vice President and |
|   | Chief Financial Officer      |
|   | March 27, 2007          |

 

----
**Exhibit    23** **CONSENT    OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**     The Board of Directors    NaviSite, Inc.:     We consent to the incorporation by reference in the registration    statement Nos. 333-138986,    333-136652,333-123114    and    333-117543    on    Forms S-3,333-132677,333-117545,333-111165,333-89987,333-67786.333-67774,333-56454,333-56452    and    333-56478 on    Forms S-8    of NaviSite, Inc. of our report dated November 7, 2007,    with respect to the consolidated balance sheets of NaviSite,    Inc. and subsidiaries as of July 31, 2007 and 2006, and the    related consolidated statements of operations, changes in    stockholders’ equity (deficit) and cash flows for each of    the years in the three-year period ended July 31, 2007, and    our report dated November 7, 2007 relating to the    consolidated financial statement schedule, which reports appear    in the July 31, 2007 Annual Report on    Form 10-K    of NaviSite, Inc.     As described in Note 2, the Company has restated the    accompanying consolidated statement of cash flows for the year    ended July 31, 2006./s/ KPMG LLP     Boston, Massachusetts     November 7, 2007
Exhibit 4.2


 


Consent of Independent Registered
Public Accounting Firm


We have issued our
report dated February 22, 2019, with respect to the financial statement of Advisors Disciplined Trust 1913 contained in Amendment
No. 2 to the Registration Statement on Form S-6 (File No. 333-227345) and related Prospectus. We consent to the use of the aforementioned
report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts”.


 


/s/ Grant
Thornton LLP


 


Chicago, Illinois


February 22, 2019
<TABLE> <S> <C>


<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUL-02-1999
<PERIOD-START>                             OCT-03-1998
<PERIOD-END>                               JAN-01-1999
<CASH>                                       9,936,000
<SECURITIES>                                         0
<RECEIVABLES>                               35,054,000
<ALLOWANCES>                                 1,000,000
<INVENTORY>                                 10,794,000
<CURRENT-ASSETS>                            56,486,000
<PP&E>                                      23,630,000
<DEPRECIATION>                              10,473,000
<TOTAL-ASSETS>                              85,832,000
<CURRENT-LIABILITIES>                       18,302,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       122,000
<OTHER-SE>                                  67,216,000
<TOTAL-LIABILITY-AND-EQUITY>                67,338,000
<SALES>                                     48,680,000
<TOTAL-REVENUES>                            48,680,000
<CGS>                                       36,508,000
<TOTAL-COSTS>                               45,546,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                               231,000
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              3,695,000
<INCOME-TAX>                                 1,440,000
<INCOME-CONTINUING>                          2,255,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,255,000
<EPS-PRIMARY>                                     0.19
<EPS-DILUTED>                                     0.18
        


</TABLE>
#### Tom CLOWERS Plaintiff-Appellant v. Kelly CRANDDUCK; Jason Wood; Charles “Chuck” Snider; Chris C. Snider; Captain Chris Sparks; Captain Lynn Hahn; Captain Andy Lee, III; *179Doug Vanscoy; Nathan Smith; Stephanie McLemore; Rogers Judge Paul Bridges; Springdale Judge Jeff Harper; Kathy O’Kelly, Springdale Police Chief; Mike Peters, Springdale Asst. Police Chief; D. Treat, Springdale Patrolman; R. Stewart, Springdale Patrolman Defendants-Appellees

No. 16-4367

United States Court of Appeals, Eighth Circuit.

Submitted: August 7, 2017

Filed: August 14, 2017

Tom Clowers, Pro Se

JaNan A. Davis, Rainwater & Holt, Little Rock, AR, Scott Tidwell, Matthews *&*Campbell, Rogers, AR, Marshall Dale Evans, The Evans Law Firm, Fayetteville, AR, Delena C. Hurst, Attorney General’s Office, Little Rock, AR, John Lennon Wilkerson, Arkansas Municipal League, North Little Rock, AR, for Defendants-Appellees

Before COLLOTON, MURPHY, and KELLY, Circuit Judges.

PER CURIAM.

Tom Clowers appeals following the district court’s1 dismissal of his 42 U.S.C. § 1983 action, and its denial of his motion to reconsider the dismissal.

Having conducted a thorough review, we conclude that dismissal was proper for the reasons explained by the district court. See Plymouth Cty. v. Merscorp, Inc., 774 F.3d 1155, 1158 (8th Cir. 2014) (grant of motion to dismiss is reviewed de novo). The judgment is affirmed. See 8th Cir. R. 47B.

1

. The Honorable P.K. Holmes, III, Chief Judge, United States District Court for the Western District of Arkansas.
**EXHIBIT
      32.1 – CEO Certification**








**HEARTLAND,
      INC.**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUNT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**








In
      connection with the Amended Annual Report of Heartland, Inc. (the
      "Company") on Form 10-KSB/A for the year ended December 31, 2006 as filed with
      the Securities and Exchange Commission on the date hereof (the "Report"), I,
      Trent Sommerville, Chief Executive Officer and Chairman of the Board of
      Directors of the Company, certify, pursuant to 18 U.S.C.ss. 1350, as added
      by
      ss. 906 of the Sarbanes-Oxley Act of 2002, that:





1.         The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





2.         The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company as of and
      for
      the period covered by the Report.








/s/
      Trent Sommerville


Trent
      Sommerville, CEO


And
      Chairman of the Board of Directors





April
      19,
      2007





A
      signed
      original of this written statement required by Section 906 of the Sarbanes-Oxley
      Act of 2002 ("Section 906"), or other document authenticating, acknowledging,
      or
      otherwise adopting the signature that appears in typed form within the
      electronic version of this written statement required by Section 906, has been
      provided to Heartland, Inc., and will be retained by Heartland, Inc. and
      furnished to the Securities and Exchange Commission or its staff upon
      request.
Jamie GEER, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D18-0432

District Court of Appeal of Florida, Second District.

March 08, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS AND NOTES THERETO INCLUDED IN THE
COMPANY'S FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1996.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                         488,000
<SECURITIES>                                         0
<RECEIVABLES>                                  778,000
<ALLOWANCES>                                         0
<INVENTORY>                                245,230,000
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             273,605,000
<CURRENT-LIABILITIES>                                0
<BONDS>                                     57,500,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       209,000
<OTHER-SE>                                  93,096,000
<TOTAL-LIABILITY-AND-EQUITY>               273,605,000
<SALES>                                     21,953,000
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                               21,225,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                787,000
<INCOME-TAX>                                   302,000
<INCOME-CONTINUING>                            485,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   485,000
<EPS-PRIMARY>                                     0.02
<EPS-DILUTED>                                     0.02
        

</TABLE>
#### Eric FLORES, Plaintiff-Appellant v. R. MOORE, Senior Warden; D. Lofton, Assistant Warden, Defendants-Appellees

No. 16-11033

United States Court of Appeals, Fifth Circuit.

Filed May 30, 2017

Eric Flores, Pro Se

Before JOLLY, DAVIS, and SOUTHWICK, Circuit Judges.

PER CURIAM: *

Eric Flores, Texas prisoner # 2051801, moves this court for authorization to proceed in forma pauperis (IFP) following the district court’s dismissal of his 42 U.S.C. § 1983 complaint. As Flores has raised only fanciful allegations, including claims that he has already been executed and that the defendants have used technology from outer space to harm him and his family, he has failed to show that he should be allowed to proceed IFP on appeal under 28 U.S.C. § 1915(g) or that his appeal of the district court’s judgment presents a non-*154frivolous issue. *See Banos v. O’Guin,*144 F.3d 883, 885 (5th Cir. 1998); *Carson v. Polley,*689 F.2d 562, 586 (5th Cir. 1982). Flores’s motion for leave to proceed IFP is denied.

The facts surrounding the IFP decision are inextricably intertwined with the merits of the appeal. *See Baugh v. Taylor,*117 F.3d 197, 202 & n.24 (5th Cir. 1997). The appeal presents no nonfrivolous issues and is dismissed as frivolous. *See*5th Cir. R. 42.2. Flores is WARNED that any future frivolous, repetitive, or otherwise abusive filings will subject him to additional and progressively more severe sanctions. Flores is DIRECTED to review all pending matters and move to dismiss any that are frivolous, repetitive, or otherwise abusive.

IFP DENIED; APPEAL DISMISSED AS FRIVOLOUS; SANCTION WARNING ISSUED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theAnnual Report of Golden Health Holdings, Inc. (the “Company”) on Form 10-KSBfor the period ended September 30, 2004 filed with theSecurities and Exchange Commission (the “Report”), we, Hoi-ho Kiu, Chief Executive Officer of the Company, and Maggie Kwok, Chief Financial Officer of the Company, certify,pursuant to 18 U.S. C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that:

 

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)           The information contained in the Report fairly presents,in all material respects, the consolidated financial condition of the Companyas of the dates presented and the consolidated result of operations of theCompany for the periods presented.

 

 
|   | /s/ Hoi-ho Kiu          |   |
|--------|-------------------------|--------|
|   | Hoi-ho Kiu              |
|   | Chief Executive Officer |
|   | December 18, 2005  |
|   |                    |
|   |                    |
|   | /s/ Maggie Kwok         |   |
|   | Maggie Kwok             |
|   | Chief Financial Officer |
|   | December 18, 2005  |
|        |                         |        |  |

 

----
Order filed October 11, 2018

In The 

## Fourteenth Court of Appeals

____________ NO. 14

- 18

- 00434

- CV

____________ IN THE ESTATE OF KIM BERLIE DENISE MENARD , INCAPACITATED

On Appeal from Probate Court No

. 3 Harris County, Texas Trial Court Cause No. 261740

- 401



### O R D E R
Appellant Jessie Smith’s brief was due October 1, 2018

. No brief or motion
for extension of time has been filed.
Unless appellant files a brief with this court on or before October 31 , 2018
, the court will dismiss the appeal for want of prosecution. See Tex. R. App. P. 42.3(b).

PER CURIAM
rdhl_Ex4_6


		
			Exhibit 4.6
		

		
			Confidential
		

		
			 
		

		
			THE SYMBOL "[****]" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMIITTED
PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL HAS BEEN FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
		

		
			 
		

		
			Amendment #1
To
		

		
			EXCLUSIVE LICENSE AGREEMENT
		

		
			 
		

		
			Apogee Biotechnology Corporation
and
RedHill Biopharma Ltd
		

		
			 
		

		
			This Amendment is entered into effective as of the date of the last signature below (the "Effective Date") by and between RedHill Biopharma Ltd ("RedHill") and Apogee Biotechnology Corporation ("Apogee") to amend the terms of that Exclusive License Agreement entered into by the parties effective March 30, 2015 ("Agreement").
		

		
			 
		

		
			NOW, THEREFORE, the mutual covenants set forth herein, the parties agree to amend the terms of the Agreement as follows:
		

		
			 
		

		
			1.          Clause 6.2.1 is hereby modified to: [****] days following the earlier of (i) [****] and (ii) [****]: Two Million US Dollars ($2,000,000).
		

		
			 
		

		
			2.          All other terms of the Agreement are unchanged and remain in full force and effect.
		

		
			 
		

		
			WHEREFORE, the parties hereunto have caused this Amendment to be executed by their duly authorized representatives as of the date of the last party to sign to be effective and in agreement.
		

		
			 
		

		
			
		

		
			


		 


 



		

		
			 
		

			
					
						RedHill Biopharma Ltd

					
					
						    

					
					
						Apogee Biotechnology Corporation

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						By:

					
					
						/s/ Micha Ben Chorin

					
					
						 

					
					
						By: 

					
					
						/s/ Charles D. Smith

				
	
					
						/s/ Dror Ben-Asher

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Printed Name:

					
					
						Micha Ben Chorin

					
					
						 

					
					
						Printed Name:

					
					
						Charles D. Smith

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Dror Ben-Asher

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						Title:

					
					
						CFO

					
					
						 

					
					
						Title:

					
					
						President and CEO

				
	
					
						CEO

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						Date: 

					
					
						January 23, 2017

					
					
						 

					
					
						Date:

					
					
						January 21, 2017